Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 12, 2022
On December 12, we celebrate countries’ efforts towards achieving Universal Health Coverage (UHC) and remind leaders of the importance of UHC and their promise of #HealthForAll. Yet this year, World UHC Day takes place against a backdrop of significant fiscal pressure stemming from changing economic...
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...
Blog Post
November 23, 2022
This week is World Antimicrobial Awareness Week, a global campaign initiated by the World Health Organization (WHO) to improve awareness and understanding of AMR, yet only 44 percent of people have heard of AMR. We considered the portrayal of AMR in the media to determine how this might affect publi...
Blog Post
November 21, 2022
As the world faces multiple crises and the economic and health scars left by the pandemic are still evident, it is clear that governments are unlikely to sustain pandemic-era health spending increases in this recovery phase. How can LMICs align their plans and discourse around universal health cover...
Blog Post
October 24, 2022
Low- and middle-income countries face severe health budget constraints while also dealing with complex and evolving disease burdens. Ministries of health need cost information to allocate resources efficiently. We've developed a step-by-step guide to a method known as “time-driven activity-based cos...
Blog Post
September 26, 2022
Antimicrobial resistance is a major global problem. Today, drug resistant infections kill an estimated 1.27 million people per year, and low- and middle-income countries bear the brunt of AMR-related deaths and illness. Changing how we buy antimicrobials can help solve the problem.